Connection

Bonaventura Clotet to Anti-Retroviral Agents

Back to Details
This is a "connection" page, showing publications Bonaventura Clotet has written about Anti-Retroviral Agents.
Bonaventura Clotet
Connection Strength
0.279
Anti-Retroviral Agents
  1. Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Sci Rep. 2017 09 15; 7(1):11711.
    View in: PubMed
    Score: 0.093
  2. Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother. 2015 Apr; 70(4):1139-45.
    View in: PubMed
    Score: 0.077
  3. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin. 2004 Dec; 22(10):564-642.
    View in: PubMed
    Score: 0.038
  4. Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men. PLoS One. 2018; 13(8):e0199033.
    View in: PubMed
    Score: 0.025
  5. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan 14; 32(2):149-160.
    View in: PubMed
    Score: 0.024
  6. Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One. 2017; 12(8):e0182547.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.